Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
72.14
-0.03 (-0.04%)
At close: Jan 31, 2025, 4:00 PM
72.20
+0.06 (0.08%)
After-hours: Jan 31, 2025, 5:00 PM EST
Hologic Employees
Hologic had 6,990 employees as of September 30, 2023. The number of employees increased by 46 or 0.66% compared to the previous year.
Employees
6,990
Change (1Y)
46
Growth (1Y)
0.66%
Revenue / Employee
$576,581
Profits / Employee
$112,947
Market Cap
16.28B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 6,990 | 46 | 0.66% |
Sep 24, 2022 | 6,944 | 239 | 3.56% |
Sep 25, 2021 | 6,705 | 891 | 15.33% |
Sep 26, 2020 | 5,814 | -664 | -10.25% |
Sep 28, 2019 | 6,478 | 226 | 3.61% |
Sep 29, 2018 | 6,252 | 19 | 0.30% |
Sep 30, 2017 | 6,233 | 900 | 16.88% |
Sep 24, 2016 | 5,333 | 43 | 0.81% |
Sep 26, 2015 | 5,290 | -61 | -1.14% |
Sep 27, 2014 | 5,351 | -264 | -4.70% |
Sep 28, 2013 | 5,615 | -542 | -8.80% |
Sep 29, 2012 | 6,157 | 1,138 | 22.67% |
Sep 24, 2011 | 5,019 | 799 | 18.93% |
Sep 25, 2010 | 4,220 | 261 | 6.59% |
Sep 26, 2009 | 3,959 | 26 | 0.66% |
Oct 25, 2008 | 3,933 | 353 | 9.86% |
Nov 12, 2007 | 3,580 | 1,963 | 121.40% |
Nov 17, 2006 | 1,617 | 747 | 85.86% |
Nov 19, 2005 | 870 | 109 | 14.32% |
Nov 30, 2004 | 761 | 39 | 5.40% |
Nov 30, 2003 | 722 | -7 | -0.96% |
Nov 30, 2002 | 729 | -51 | -6.54% |
Nov 30, 2001 | 780 | -66 | -7.80% |
Nov 30, 2000 | 846 | 410 | 94.04% |
Nov 30, 1999 | 436 | 40 | 10.10% |
Nov 30, 1998 | 396 | 57 | 16.81% |
Nov 30, 1997 | 339 | 45 | 15.31% |
Nov 30, 1996 | 294 | 103 | 53.93% |
Nov 30, 1995 | 191 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
HOLX News
- 11 days ago - New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide - Business Wire
- 15 days ago - Hologic: Reasonably, But Not Compellingly Valued - Seeking Alpha
- 20 days ago - Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 - Business Wire
- 25 days ago - Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 26 days ago - Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 - Business Wire
- 26 days ago - Hologic Completes Acquisition of Gynesonics, Inc. - Business Wire
- 6 weeks ago - Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC - Business Wire
- 7 weeks ago - Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines - Business Wire